Ciclesonide# | Fluticasone¶ | p-value | |||
Subjects | eNO | Subjects | eNO | ||
Baseline | |||||
Alveolar | 18 | 4.78 (3.52–8.12) | 17 | 5.52 (4.72–6.83) | 0.51 |
Bronchial | 18 | 0.66 (0.49–1.39) | 17 | 0.79 (0.67–1.12) | 0.41 |
Post-treatment | |||||
Alveolar | 16 | 4.61 (3.29–6.91) | 16 | 4.73 (3.69–5.69) | 0.88 |
Bronchial | 16 | 0.67 (0.42–1.44) | 16 | 0.82 (0.46–1.33) | 0.90 |
Differences | |||||
Alveolar | 15 | 0.40 (−0.82–3.85) | 15 | -1.06 (-2.41–0.07) | 0.03 |
Bronchial | 15 | 0.17 (−0.11–0.70) | 15 | 0.02 (-0.15–0.09) | 0.22 |
Data are presented as n or median (interquartile range), unless otherwise stated. Between-group differences were tested with Mann–Whitney U-test. Alveolar eNO is expressed in ppb and bronical eNO in nL·s−1. #: n = 19; ¶: n = 18.